Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by tdon1229on Apr 14, 2020 7:44pm

75 Views

Post# 30909642

RE:Brazilian HCQ trial halted after 11 die

Datawork,

You need to reread the article ... it wasn't an HCQ trial ... they were using the natural drug chloroquine which is known to have a different profile of more serious side effects than does the chemically-formulated hydroxychloroquine ... that's why the trials in this country are using HCQ and not chloroquine ... and actually HCQ acts primarily to open the gate so the Zinc ions can pass throught the cell wall, move from extracellular to intracellular, and do the major work of inhibiting the replication of the virus within the cell. The scientific community makes no pretense that they really don't know much about HCQ and what it does at the cellular level.

Regards,
TDON

Bullboard Posts

AI companies to invest in